September 2022

A new study from Israel found that the risk of developing myocarditis among males ages 16 to 19 years was about 1 in 15,000 after third dose of the Pfizer-BioNTech COVID-19 vaccine, and the cases were rare and mild, according to new research published today in the American Heart Association’s flagship journal Circulation.

AstraZeneca’s Forxiga (dapagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor, has been approved in China to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease (ESKD), cardiovascular (CV) death and hospitalisation for heart failure (hHF) in adults with chronic kidney disease (CKD) at risk of progression with and without type-2 diabetes (T2D).

Aragen is a trusted R&D and manufacturing partner to the global life sciences industry. From concept to commercial, we transform your ideas into solutions for better health. Whether large pharma or biotech, an agrochemical or animal health company, we provide you global resources and proven capabilities at every stage of the biopharma lifecycle, in small and large molecules. Our ability to offer end-to-end solutions or support standalone programs is underpinned by an innovation mindset, enabling technologies, and a partnership approach to every engagement.

Lupin and DKSH have signed an exclusive license and supply agreement to commercialize five of Alvotechs proposed biosimilars in the Philippines. The biosimilars planned under this agreement include biosimilar Prolia, Xgeva, Simponi, and Eylea as well as two undisclosed proposed biosimilars for immunology and oncology.

Aizant is an integrated drug development solutions provider. Aizant was established by experienced pharmaceutical professionals with global exposure. We are a rapidly growing formulation CDMO and CRO with a diverse portfolio of capabilities partnering with health care companies specializing in new molecular entities (NMEs), generics (ANDAs) and over the counter (OTCs) products globally.

Post : Executive / Senior Executive

Vee Technologies is a premier consulting and professional services company, offering cutting-edge solutions to organizations around the world. With a powerful blend of people, processes and groundbreaking technology-enabled solutions, we streamline operations, increase cash flow, reduce costs and maximize compliance while providing an edge over the competition.

Post : Medical Coder / Sr. Medical Coder / QA / TL

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen.

Eisai Pharmaceuticals India is a 100 % subsidiary company of Eisai. Co.Ltd Japan and is a human health care company. Eisai India’s main manufacturing is in the integrated campus at Visakhapatnam, Andhra Pradesh. This facility is used to manufacture, package and perform testing for oral solid dosage products. Eisai India’s manufacturing site is part of Eisai’s global production structure to ensure a stable supply of high-quality products.

Vital Pharma is an endeavour to offer trustworthy partnership comprising superior quality products and services par excellence in Contract Manufacturing, Animal Nutrition, Human Nutrition, Aquaculture and Vitamin pre-mixes. Vital Therapeutics & Formulations is designed to meet International Regulatory requirements such as CGMP, WHO, ISO 9001 & FSSC 22000 and recognised for abiding to vigorous quality and service standards for product development, analytical services, packaging and regulatory services.